J.P. Marvel Investment Advisors, LLC Alnylam Pharmaceuticals, Inc. Transaction History
J.P. Marvel Investment Advisors, LLC
- $563 Million
- Q1 2025
A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Alnylam Pharmaceuticals, Inc. stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 4,000 shares of ALNY stock, worth $1.09 Million. This represents 0.19% of its overall portfolio holdings.
Number of Shares
4,000
Previous 4,000
-0.0%
Holding current value
$1.09 Million
Previous $941,000
14.77%
% of portfolio
0.19%
Previous 0.16%
Shares
9 transactions
Others Institutions Holding ALNY
# of Institutions
685Shares Held
109MCall Options Held
836KPut Options Held
784K-
Capital World Investors Los Angeles, CA16.7MShares$4.58 Billion0.76% of portfolio
-
Vanguard Group Inc Valley Forge, PA13.1MShares$3.57 Billion0.07% of portfolio
-
Black Rock Inc. New York, NY9.55MShares$2.61 Billion0.05% of portfolio
-
Capital Research Global Investors Los Angeles, CA7.15MShares$1.96 Billion0.44% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD4.38MShares$1.2 Billion0.64% of portfolio
About ALNYLAM PHARMACEUTICALS, INC.
- Ticker ALNY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 123,028,000
- Market Cap $33.7B
- Description
- Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...